Overview A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19 Status: Completed Trial end date: 2021-07-30 Target enrollment: Participant gender: Summary The study will assess the efficacy and safety of Brilacidin for the treatment of COVID-19 in hospitalized participants Phase: Phase 2 Details Lead Sponsor: Innovation Pharmaceuticals, Inc.